Cash Equivalents Cash and Cash Equivalents, Unrestricted Cash and Cash Equivalents, Policy [Policy Text Block] Supplementary cash flow information: Supplemental Cash Flow Information [Abstract] Customer [Domain] Customer [Domain] Contractual value of future grants to outside directors not previously employed Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Contractual Grants To Future Directors Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Contractual Grants To Future Directors Net Loss per Common Share Earnings Per Share, Policy [Policy Text Block] State Current State and Local Tax Expense (Benefit) Leasehold improvements Leasehold Improvements [Member] Net loss Net loss Net Income (Loss) Attributable to Parent Unvested free shares modified (in shares) Business Acquisition, Nonvested Acquiree Awards Modified Business Acquisition, Nonvested Acquiree Awards Modified Effective Income Tax Rate Reconciliation, Amount [Abstract] Effective Income Tax Rate Reconciliation, Amount [Abstract] Right-of-use assets - operating leases Operating Lease, Right-of-Use Asset Schedule of Purchase Price and Nonrecurring Post-compensation Expense Schedule of Business Acquisitions, by Acquisition [Table Text Block] Net operating loss carryforwards Deferred Tax Assets, Operating Loss Carryforwards Preferred stock, shares outstanding (in shares) Preferred Stock, Shares Outstanding Accrued compensation expense Employee-related Liabilities, Current Income Statement Location [Axis] Income Statement Location [Axis] Accumulated Amortization Finite-Lived Intangible Assets, Accumulated Amortization Transaction costs Business Combination, Acquisition Related Costs Statistical Measurement [Domain] Statistical Measurement [Domain] HalioDx Inc. HalioDx Inc. [Member] HalioDx Inc. Segment Reporting Segment Reporting, Policy [Policy Text Block] Security Exchange Name Security Exchange Name Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Proceeds from the sale of property and equipment Proceeds from Sale of Property, Plant, and Equipment Additional paid-in capital Additional Paid in Capital, Common Stock Right-of-use assets, financing lease Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Financing Lease, Right-Of-Use Asset Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Financing Lease, Right-Of-Use Asset Canceled (in shares) Canceled (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Weighted average remaining lease term Operating Lease, Weighted Average Remaining Lease Term Foreign Currency Translation Foreign Currency Transactions and Translations Policy [Policy Text Block] COVID 19 Pandemic COVID 19 Pandemic [Member] Represents the COVID-19 pandemic. Provision of data Biopharmaceutical And Other - Provision of Data [Member] Biopharmaceutical And Other - Provision of Data Other assets Other Assets, Noncurrent French Research Tax Credits Foreign Tax Credit, Policy [Policy Text Block] Foreign Tax Credit, Policy Impairment loss Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Expected dividend yield Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate Shares available for issuance (in shares) Number of shares available for issuance (in shares) Balance at the beginning of the period (in shares) Balance at the end of the period (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant Retirement Benefits [Abstract] Retirement Benefits [Abstract] Net (decrease) increase in cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Entity File Number Entity File Number Business Acquisition, Pro Forma Information, Nonrecurring Adjustments [Table] Business Acquisition, Pro Forma Information, Nonrecurring Adjustments [Table] Schedule of Other Income (Loss) Schedule of Other Nonoperating Income (Expense) [Table Text Block] Other acquired intangibles Deferred Tax Liabilities, Intangible Assets Intrinsic value of stock options exercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value Increase (decrease) in fair value of accounts receivable acquired Business Combination, Increase (Decrease) In Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables Business Combination, Increase (Decrease) In Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables Acquisition of HalioDx, net of cash acquired Payments to Acquire Business Two, Net of Cash Acquired Gross receivables concentration risk Credit Concentration Risk [Member] Deferred tax liability Deferred tax liability Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Intangible asset amortization Amortization of Intangible Assets Estimated useful life Acquired Finite-lived Intangible Assets, Weighted Average Useful Life Gross increases—tax position in prior period Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions Discount rate Operating Lease, Weighted Average Discount Rate, Percent Shares of common stock subject to outstanding options (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Research and development Research and Development Expense [Member] Required service period associated with cash consideration holdback Deferred Compensation Arrangement with Individual, Requisite Service Period Sale of Stock [Axis] Sale of Stock [Axis] HalioDx customer relationships HalioDx Customer Relationships [Member] HalioDx Customer Relationships Operating loss associated with acquisition Business Combination, Pro Forma Information, Earnings or Loss of Acquiree since Acquisition Date, Actual Net deferred tax assets Deferred Tax Assets, Net of Valuation Allowance Restricted Cash Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block] Business Acquisition [Axis] Business Acquisition [Axis] Title of Individual [Domain] Title of Individual [Domain] Schedule of Operating Leased Assets [Table] Schedule of Operating Leased Assets [Table] Income Tax Authority, Name [Axis] Income Tax Authority, Name [Axis] Award Type [Domain] Award Type [Domain] Local Phone Number Local Phone Number Credit Facility [Domain] Credit Facility [Domain] Assets Assets [Abstract] Weighted Average Remaining Contractual Life of Stock Options (Years) Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] Operating Loss Carryforwards [Line Items] Operating Loss Carryforwards [Line Items] Options vested and exercisable at the end of the period (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Options vested and expected to vest at the end of the period (in USD per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Aggregate Intrinsic Value of Stock Options Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest [Abstract] Silicon Valley Bank Silicon Valley Bank [Member] Silicon Valley Bank [Member] Concentration risk Concentration Risk, Percentage Preferred stock, $0.001 par value; 5,000,000 shares authorized, no shares issued and outstanding as of December 31, 2021 and 2020 Preferred Stock, Value, Issued Property and Equipment Property, Plant and Equipment, Policy [Policy Text Block] Options issued and outstanding (in shares) Balance at beginning of the period (in shares) Balance at the end of the period (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Shares issued, price per share (in USD per share) Shares Issued, Price Per Share Accumulated Deficit Retained Earnings [Member] Prepaid expenses and other current assets Increase (Decrease) in Prepaid Expense and Other Assets Term of lease Lessee, Operating Lease, Lease Not yet Commenced, Term of Contract Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] HalioDx HalioDx [Member] HalioDx SAS Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Related Party [Axis] Related Party [Axis] LymphMark product technology LymphMark product technology LymphMark Product Technology [Member] Represents LymphMark product technology. Measurement input Business Combination, Contingent Consideration, Liability, Measurement Input Secured Debt Secured Debt [Member] Accounts receivable Increase (Decrease) in Accounts Receivable Purchases of property and equipment included in accounts payable and accrued liabilities Capital Expenditures Incurred but Not yet Paid Indefinite-lived Intangible Assets Goodwill and Intangible Assets, Intangible Assets, Indefinite-Lived, Policy [Policy Text Block] Supplies inventory Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory Schedule of Supplemental Pro Forma Information Business Acquisition, Pro Forma Information [Table Text Block] Schedule of Significant Components of the Company's Deferred Tax Assets and Liabilities Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] NanoString NanoString NanoString [Member] NanoString [Member] Entity Well-known Seasoned Issuer Entity Well-known Seasoned Issuer Stock-based compensation expense (non-employee) Adjustments to Additional Paid in Capital Share Based Compensation Non Employee Amount of increase in additional paid-in capital (APIC) resulting from non-employee stock-based compensation expense. Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Accruals and other Deferred Tax Assets, Accruals, Deferred Rent and Other Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from non-current accruals, deferred rent and other reserves and accruals not separately disclosed. Periodic payment terms, balloon payment to be paid Debt Instrument, Periodic Payment Terms, Balloon Payment to be Paid Fair value of free shares modified (in shares) Business Acquisition, Nonvested Aquiree Awards Modified, Fair Value Business Acquisition, Nonvested Aquiree Awards Modified, Fair Value Stock-based Compensation, non-employees Non Employee Stock Option [Member] An arrangement whereby a non-employee is entitled to receive in the future, subject to vesting and other restrictions, a number of shares in the entity at a specified price, as defined in the agreement. Payment of financial lease liability Finance Lease, Principal Payments Stock-based compensation expense (employee) Adjustments to Additional Paid in Capital Share Based Compensation Employee Amount of increase in additional paid-in capital (APIC) resulting from employee stock-based compensation expense. Deferred revenue Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Net loss per common share, basic (in USD per share) Earnings Per Share, Basic Current portion of acquisition-related contingent consideration Short term contingent considerations Business Combination, Contingent Consideration, Liability, Current Operating lease expense Operating Lease, Expense Dr. Tina S. Nova, Ph.D. Dr. Tina S. Nova, Ph.D. [Member] Dr. Tina S. Nova, Ph.D. 2024 Lessee, Operating Lease, Liability, to be Paid, Year Three Thereafter Finite-Lived Intangible Asset, Expected Amortization, after Year Five Non-substantive Employee Non-substantive Employee [Member] Non-substantive Employee Percepta product technology Percepta Product Technology [Member] Percepta Technology [Member] Net identifiable assets acquired Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net Schedule of Revenue Disaggregation of Revenue [Table Text Block] Employer contributions to the plan Defined Contribution Plan, Cost Pre-combination services associated with options vested Payments For Purchase of Acquiree Vested Awards Business Combination, Consideration Transferred, Liabilities Incurred Associated with Vested Acquiree Awards Fair value of finite-lived intangible assets Finite-lived intangible assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles Tax portion of vested restricted stock units Share-based Payment Arrangement, Decrease for Tax Withholding Obligation Net deferred taxes Deferred Tax Liabilities, Net Cash paid for amounts included in the measurement of lease liabilities Operating Lease, Payments Collaboration milestones Biopharmaceutical And Other - Collaboration Milestones [Member] Biopharmaceutical And Other - Collaboration Milestones NSO Non Statutory Stock Options [Member] Represents information pertaining to non statutory stock options (NSOs). Property and equipment Deferred Tax Liabilities, Property, Plant and Equipment Research and Development Research and Development Expense, Policy [Policy Text Block] Auditor Information [Abstract] Auditor Information Considerations paid in acquisition Total Business Combination, Consideration Transferred Goodwill [Roll Forward] Goodwill [Roll Forward] Entity Voluntary Filers Entity Voluntary Filers Estimated grant date fair value of options to purchase common stock vested Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value Plan Name [Axis] Plan Name [Axis] Long-term debt balance outstanding Net debt obligation Long-term Debt Finance right-of-use assets Finance Lease, Right-of-Use Asset, after Accumulated Amortization Other state income tax purposes Other States, Not Separately Disclosed [Member] Other States, Not Separately Disclosed [Member] Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward] Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward] Goodwill impairment Goodwill, Impairment Loss Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] State tax (net of federal benefit) Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount Entity Small Business Entity Small Business Gross increases—current period tax position Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions Contract manufacturing Biopharmaceutical And Other - Contract Manufacturing [Member] Biopharmaceutical And Other - Contract Manufacturing Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] Total liabilities and stockholders' equity Liabilities and Equity Accrued other Other Accrued Liabilities, Current Term Loan Advance Term Loan Advance [Member] Represents term loan advance. Other Income and Expenses [Abstract] Current portion of deferred revenue Contract with Customer, Liability, Current 2026 Lessee, Operating Lease, Liability, to be Paid, Year Five Scenario [Axis] Scenario [Axis] Exercised (in USD per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Restricted cash Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Restricted Cash Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Restricted Cash Concentration Risk [Line Items] Concentration Risk [Line Items] Indefinite-lived intangible assets, impairment Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) Liabilities and Stockholders' Equity Liabilities and Equity [Abstract] HalioDx customer backlog HalioDx Customer Backlog [Member] HalioDx Customer Backlog Proceeds from issuance of common stock in a public offering, net of issuance costs Proceeds from Issuance Initial Public Offering Accounts payable Increase (Decrease) in Accounts Payable HalioDx SAS HalioDx SAS [Member] HalioDx SAS Organization and Description of Business Business Description and Basis of Presentation [Text Block] Operating activities Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract] Net Loss Per Share Earnings Per Share [Text Block] Operating expenses: Operating Expenses [Abstract] French research tax credits Other Nonoperating Income (Expense), Foreign Tax Credit Foreign Tax Credit, Nonoperating Entity Interactive Data Current Entity Interactive Data Current 2025 Finite-Lived Intangible Asset, Expected Amortization, Year Four Acquisition of NanoString diagnostics platform Payments to Acquire Business Three, Net of Cash Acquired Value of grants to non-employee directors Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Contractual Grants To Existing Non-employee Directors Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Contractual Grants To Existing Non-employee Directors Nonrecurring Adjustment [Domain] Nonrecurring Adjustment [Domain] Minimum Minimum [Member] Revaluation of acquisition-related contingent consideration Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability 2023 Lessee, Operating Lease, Liability, to be Paid, Year Two Effect of foreign currency on cash, cash equivalents and restricted cash Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Schedule of Reserved Shares of Common Stock for Issuance Schedule of Stock by Class [Table Text Block] Other Other Nonoperating Income (Expense), Other Other Nonoperating Income (Expense), Other Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized 401(k) Plan Postemployment Retirement Benefits [Member] Unrecognized tax benefits Unrecognized tax benefits, beginning of period Unrecognized tax benefits, end of period Unrecognized Tax Benefits Gross deferred tax assets Deferred Tax Assets, Gross Income Tax Authority [Domain] Income Tax Authority [Domain] Entity Common Stock, Shares Outstanding (in shares) Entity Common Stock, Shares Outstanding Decipher product technology Decipher BioSciences Product Technology [Member] Decipher BioSciences Product Technology Entity Address, State or Province Entity Address, State or Province Nonrecurring post-combination compensation expense associated nonvested options Considerations Payable To Acquiree Nonvested Award Holders Considerations Payable To Acquiree Nonvested Award Holders Equity interest acquired Business Acquisition, Percentage of Voting Interests Acquired Issuance of common stock for acquisition Stock Issued During Period, Value, Acquisitions Current liabilities: Liabilities, Current [Abstract] Operating lease liability Increase (Decrease) in Operating Lease Liability Restricted cash Restricted cash Long term deposits Restricted Cash and Cash Equivalents, Noncurrent Acceleration and cash settlement of unvested acquiree employee stock awards Share-based Payment Arrangement, Accelerated Cost General and administrative General and Administrative Expense Acquisition of Decipher Biosciences, net of cash acquired Payments to Acquire Businesses, Net of Cash Acquired Debt Debt Disclosure [Text Block] Nonrecurring Adjustment [Axis] Nonrecurring Adjustment [Axis] Financing lease liability, net of current portion Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Financing Lease Liability Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Financing Lease Liability Beginning balance (in shares) Ending balance (in shares) Shares, Outstanding Schedule of Components of Income Tax Expense (Benefit) Schedule of Components of Income Tax Expense (Benefit) [Table Text Block] Options vested and exercisable at the end of the period (in USD per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price NanoString intangibles and goodwill Deferred Tax Assets, Goodwill and Intangible Assets Line of credit Line of Credit [Member] Scenario, Plan Scenario, Plan [Member] Stock Incentive Plans Share-based Payment Arrangement [Text Block] Fair Value Measurement Inputs and Valuation Techniques [Line Items] Fair Value Measurement Inputs and Valuation Techniques [Line Items] Accounting Policies [Abstract] Accounting Policies [Abstract] Remaining contractual life of stock options at beginning and end of period Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term nCounter Dx license nCounter Dx license nCounter Dx License [Member] nCounter Dx License [Member] Payments of stock issuance costs Payments of Stock Issuance Costs Term of options to person owning more than 10% of voting power stock Share Based Compensation Arrangement by Share Based Payment Award, Term of Options Granted to Employees Who Owned Specified Percentage of Class of Stock Represents the term of options granted to persons owning stock representing specified percentage of voting power of all classes of stock, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Interest on end-of-term debt obligation Debt Instrument, End of Term Payment Interest Amount and Prepayment Penalty Debt instrument, End of Term Payment Interest Amount Federal Current Federal Tax Expense (Benefit) Present value of future lease payments Operating Lease, Liability Gain (loss) on currency revaluation Other Nonoperating Income (Expense), Foreign Currency Translation Gain (Loss) Foreign Currency Translation Gain (Loss), Nonoperating Document Transition Report Document Transition Report Effect of foreign currency on operations Foreign Currency Transaction Gain (Loss), before Tax Common stock, $0.001 par value; 125,000,000 shares authorized, 71,123,108 and 58,200,526 shares issued and outstanding as of December 31, 2021 and 2020, respectively Common Stock, Value, Issued Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Equity Interest Issued or Issuable, Type [Domain] Equity Interest Issued or Issuable, Type [Domain] Period over which unrecognized compensation expense expected to be recognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Revenue concentration risk Customer Concentration Risk [Member] Goodwill acquired Goodwill, Acquired During Period Basis of Presentation Basis of Accounting, Policy [Policy Text Block] (Decrease) increase in cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect Commitments and contingencies Commitments and Contingencies Headquarters And Laboratory Facilities South San Francisco, San Diego, And Austin Headquarters And Laboratory Facilities South San Francisco, San Diego, And Austin [Member] Headquarters And Laboratory Facilities South San Francisco, San Diego, And Austin Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Prosigna customer relationships Prosigna customer relationships Prosigna Customer Relationships [Member] Prosigna Customer Relationships Entity Emerging Growth Company Entity Emerging Growth Company Free Shares Free Ordinary Share Awards [Member] Free Ordinary Share Awards Right-of-use assets, operating lease Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease, Right-Of-Use Asset Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease, Right-Of-Use Asset Write-down of excess supplies Inventory Write-down Business Combination Business Combination Disclosure [Text Block] ICFR Auditor Attestation Flag ICFR Auditor Attestation Flag Components of Other Income, net Other Nonoperating Income and Expense [Text Block] Schedule of Assumptions Used to Calculate Fair Value of Stock Options Using the Black-Scholes Model Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Probability of achievement Measurement Input Probability Of Achievement [Member] Measurement Input Probability Of Achievement Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Foreign Deferred Foreign Income Tax Expense (Benefit) Auditor Name Auditor Name Cover [Abstract] Cover [Abstract] Goodwill [Line Items] Goodwill [Line Items] Total operating expenses Costs and Expenses Net loss Business Acquisition, Pro Forma Net Income (Loss) Percentage of cash consideration holdback placed in escrow Business Combination, Contingent Consideration, Liability, Percentage In Escrow Business Combination, Contingent Consideration, Liability, Percentage In Escrow Post-Combination Compensation Expense Acquisition-related Costs [Member] Less: amount representing interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount California CALIFORNIA Income Tax Authority [Axis] Income Tax Authority [Axis] Proceeds from issuance of common stock Sale of Stock, Consideration Received on Transaction Medicare Medicare [Member] Represents information pertaining to Medicare, a significant third-party payer. Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Financial Instrument [Axis] Financial Instrument [Axis] Shares transferred in acquisition (in shares) Business Acquisition, Equity Interest Issued or Issuable, Number of Shares Accrued liabilities Total accrued liabilities Accrued Liabilities, Current Total revenue Revenue from Contract with Customer, Excluding Assessed Tax Stock-based compensation Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost Current: Current Income Tax Expense (Benefit), Continuing Operations [Abstract] Dr. Robert S. Epstein, M.D., M.S. Dr. Robert S. Epstein, M.D., M.S. [Member] Dr. Robert S. Epstein, M.D., M.S. Employee stock options Share-based Payment Arrangement, Option [Member] Issuance costs Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs Equity [Abstract] Equity [Abstract] Shares granted as annual grant (in shares) Share Based Compensation Arrangement by Share Based Payment Award, Options, Annual Grants Gross number of share options (or share units) granted to each individual as an annual grant. Measurement Input Type [Domain] Measurement Input Type [Domain] Operating Loss Carryforwards [Table] Operating Loss Carryforwards [Table] Common Stock Common Stock Common Stock [Member] Variable Rate [Axis] Variable Rate [Axis] Foreign Income (Loss) from Continuing Operations before Income Taxes, Foreign ISO Incentive Stock Options [Member] Represents information pertaining to incentive stock options (ISOs). Loss from operations Income (loss) from operations Operating Income (Loss) Decipher Biosciences and HalioDX Decipher Biosciences and HalioDX [Member] Decipher Biosciences and HalioDX Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Purchase of equity securities Payments to Acquire Long-term Investments Current portion of operating lease liabilities Less: short-term lease liabilities Operating Lease, Liability, Current 2023 Finite-Lived Intangible Asset, Expected Amortization, Year Two Increase (Decrease) in Stockholders' Equity [Rollforward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Document Fiscal Year Focus Document Fiscal Year Focus Stock-based compensation Share-based Payment Arrangement, Noncash Expense Variable Rate [Domain] Variable Rate [Domain] Additional Paid-in Capital Additional Paid-in Capital [Member] Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Depreciation and amortization expense Depreciation Payments to board of directors members Related Party Transaction, Amounts of Transaction Long-term Debt, Type [Domain] Long-term Debt, Type [Domain] Revenues associated with acquisition Business Combination, Pro Forma Information, Revenue of Acquiree since Acquisition Date, Actual Number of votes for each share of stock Voting Rights for Each Share of Stock Represents the number of votes for each share of stock. Accrued liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accrued Liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accrued Liabilities Cash paid for tax Income Taxes Paid Stock based compensation - excess benefit Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount Other income, net Other income, net Other Nonoperating Income (Expense) Interest expense Other Nonoperating Income (Expense), Interest Expense Interest Expense, Nonoperating Sale of common stock in a public offering, net of offering costs (in shares) Stock Issued And Sold During Period, Shares, In Private Placement Number of shares issued and sold during the period in a private placement. Outside director Outside Director [Member] Nonemployee serving on the board of directors (who collectively have responsibility for governing the entity). Shares issued for purchase consideration for a business combination Stock Issued Purchases of property and equipment Payments to Acquire Property, Plant, and Equipment Valuation allowance Tax Credit Carryforward, Valuation Allowance Current portion of other liabilities Other Liabilities, Current Schedule of Intangible Assets Acquired Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block] Business Combinations [Abstract] Business Combinations [Abstract] Maximum Maximum [Member] Share-based Payment Arrangement [Abstract] Share-based Payment Arrangement [Abstract] Net deferred tax liabilities Deferred Tax Liabilities, Netting Amounts Deferred Tax Liabilities, Netting Amounts Total liabilities Liabilities End-of-term debt obligation Debt Instrument, End Of Term Payment, Interest Amount Debt Instrument, End Of Term Payment, Interest Amount Schedule of Accrued Liabilities Schedule of Accrued Liabilities [Table Text Block] 2022 Finite-Lived Intangible Asset, Expected Amortization, Year One Award Type [Axis] Award Type [Axis] Granted (in USD per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Balance at beginning of period Balance at end of period Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value Schedule of Future Minimum Lease Payments Under Non-cancelable Operating Leases Lessee, Operating Lease, Liability, Maturity [Table Text Block] 2008 Plan Stock Plan 2008 [Member] Represents information pertaining to the 2008 Stock Plan (the 2008 Plan). Measurement Input Type [Axis] Measurement Input Type [Axis] Total stockholders' equity Beginning balance Ending balance Stockholders' Equity Attributable to Parent Net operating loss carryforwards Operating Loss Carryforwards Balance Sheet Related Disclosures [Abstract] Balance Sheet Related Disclosures [Abstract] Common stock, shares issued (in shares) Common Stock, Shares, Issued Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued City Area Code City Area Code Options vested and exercisable at the end of the period Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value Indefinite-lived intangible assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets Prepaids and other current assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract] Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract] Annual rent Lessee, Operating Lease, Lease Not Yet Commenced, Annual Undiscounted Amount Lessee, Operating Lease, Lease Not Yet Commenced, Annual Undiscounted Amount Entity Address, City or Town Entity Address, City or Town Useful lives Property, Plant and Equipment, Useful Life Stockholders' equity: Stockholders' Equity Attributable to Parent [Abstract] Contingent consideration, changes in fair value Business Combination, Contingent Consideration, Liability, Fair Value Adjustment Business Combination, Contingent Consideration, Liability, Fair Value Adjustment Retirement Plan Type [Axis] Retirement Plan Type [Axis] Supplementary cash flow information of non-cash investing and financing activities: Noncash Investing and Financing Items [Abstract] Schedule of Reconciliation of Unrecognized Tax Benefits Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block] Income Tax Authority, Name [Domain] Income Tax Authority, Name [Domain] Software, including software developed for internal use Software and Software Development Costs [Member] Risk-free minimum interest rate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum Operating lease liabilities, net of current portion Long-term lease liabilities Operating Lease, Liability, Noncurrent Adjustments for New Accounting Pronouncements [Axis] Accounting Standards Update [Axis] Total current Current Income Tax Expense (Benefit) Debt principal Debt Instrument, Face Amount Deferred: Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract] Weighted-average maximum volatility Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum Total purchase price Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net Share price (in USD per share) Share Price Accumulated deficit Accumulated deficit Retained Earnings (Accumulated Deficit) Term of options granted Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period Fair Value Measurement Inputs and Valuation Techniques [Table] Fair Value Measurement Inputs and Valuation Techniques [Table] Restricted stock units Restricted Stock Units (RSUs) [Member] Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Schedule of Fair Value of Assets Acquired and Liabilities Assumed Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block] Issuance of common stock under employee stock purchase plan (ESPP) (in shares) Stock Issued During Period, Shares, Employee Stock Purchase Plans Entity Filer Category Entity Filer Category Finance lease liabilities Finance Lease, Liability Gross deferred tax liabilities Deferred Tax Liabilities, Gross Business Acquisition [Line Items] Business Acquisition [Line Items] Business Acquisition [Line Items] Laboratory equipment Laboratory Equipment [Member] Laboratory Equipment Income Statement [Abstract] Income Statement [Abstract] Concentration Risk [Table] Concentration Risk [Table] Entity Registrant Name Entity Registrant Name Accounts receivable Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables Benefit from income taxes Other Noncash Income Tax Expense (Benefit) Other Noncash Income Tax Expense (Benefit) Indefinite-lived intangible assets Indefinite-lived Intangible Assets (Excluding Goodwill) Proceeds from the exercise of common stock options and employee stock purchases Proceeds from Stock Options Exercised Development rights Biopharmaceutical And Other - Development Rights [Member] Biopharmaceutical And Other - Development Rights Canceled (in USD per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Income tax benefit Income tax expense (benefit) Total Income Tax Expense (Benefit) Biopharmaceutical and other revenue Biopharmaceutical And Other Biopharmaceutical And Other [Member] Biopharmaceutical [Member] Accounts receivable Accounts Receivable, after Allowance for Credit Loss, Current Amendment Flag Amendment Flag Equity Components [Axis] Equity Components [Axis] Entity Tax Identification Number Entity Tax Identification Number Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Antidilutive Securities [Axis] Antidilutive Securities [Axis] Document Fiscal Period Focus Document Fiscal Period Focus Total current assets Assets, Current Selling and marketing Selling and Marketing Expense [Member] Total future minimum lease payments Lessee, Operating Lease, Liability, to be Paid Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Concentration Risk Type [Domain] Concentration Risk Type [Domain] Accounts receivable Accounts Receivable [Member] Sale of Stock [Domain] Sale of Stock [Domain] Supplies Inventory, Net Stock-based Compensation Employee And Non Employee Stock Option Excluding Bonus Compensation [Member] An arrangement whereby an employee or non-employee is entitled to receive in the future, subject to vesting and other restrictions, a number of shares in the entity at a specified price, as defined in the agreement, excluding options granted as bonus related compensation. Change in valuation allowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount Tax portion of restricted stock units vested (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares, Tax Portion Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares, Tax Portion Schedule of Stock by Class [Table] Schedule of Stock by Class [Table] Time deposits Other Assets, Fair Value Disclosure Outside director serving as a member of Board of Directors for at least six months Outside Director Serving As Member Of Board Of Directors For At Least Six Months [Member] Represents information pertaining to outside director serving as a member of Board of Directors for at least six months. Stock-based Compensation Share-based Payment Arrangement [Policy Text Block] Federal Deferred Federal Income Tax Expense (Benefit) Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Thereafter Lessee, Operating Lease, Liability, to be Paid, after Year Five Security deposit Security Deposit Release of valuation allowance Valuation allowance against deferred tax assets Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount Fair value of awards granted Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Nonvested Unrecognized compensation expense Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Current portion of long-term debt Long-term Debt, Current Maturities Product and Service [Axis] Product and Service [Axis] Long-Lived Tangible Asset [Domain] Long-Lived Tangible Asset [Domain] Financing activities Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract] Off-Market Favorable Lease Off-Market Favorable Lease [Member] Investment in MAVIDx Equity Securities without Readily Determinable Fair Value, Amount Preferred stock, par value (in USD per share) Preferred Stock, Par or Stated Value Per Share Entity Public Float Entity Public Float Documents Incorporated by Reference Documents Incorporated by Reference [Text Block] Revenue Revenue Benchmark [Member] Weighted average fair value of options to purchase common stock granted (in USD per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Equity Component [Domain] Equity Component [Domain] Transaction costs Effective Income Tax Rate Reconciliation, Acquisition Of Business, Transaction Cost, Amount Effective Income Tax Rate Reconciliation, Acquisition Of Business, Transaction Cost, Amount Selling and marketing Selling and Marketing Expense 2022 Lessee, Operating Lease, Liability, to be Paid, Year One Change in currency translation adjustments Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Pre-combination services associated with free shares modified Share-based Payment Arrangement, Plan Modification, Incremental Cost Deferred tax assets: Components of Deferred Tax Assets [Abstract] 2013 Plan Stock Incentive Plan 2013 [Member] Represents information pertaining to the 2013 Stock Incentive Plan (the 2013 Plan). Shares issued for purchase consideration for a business combination Business Combination, Consideration Transferred, Equity Interests Issued and Issuable Statement [Line Items] Statement [Line Items] Income tax examination period Income Tax Examination Period Period which will remain open for examination by tax authorities, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Property and equipment, net Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Concentrations of Credit Risk and Other Risks and Uncertainties Concentrations of Credit and Other Risks and Uncertainties [Policy Text Block] Disclosure of accounting policy for concentrations of credit risk and other risks and uncertainties. Issuance of common stock for acquisition (in shares) Stock Issued During Period, Shares, Acquisitions Finite-lived intangible assets, impairment Impairment of Intangible Assets, Finite-lived Noncash lease expense Noncash Lease Expense The noncash portion of lease expense. Operating lease liability Deferred Tax Assets, Operating Lease Liability Deferred Tax Assets, Operating Lease Liability Weighted Average Exercise Price of Stock Options Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Retirement Plan Type [Domain] Retirement Plan Type [Domain] Federal Domestic Tax Authority [Member] 2025 Lessee, Operating Lease, Liability, to be Paid, Year Four Total intangible assets Intangible Assets, Gross (Excluding Goodwill) Debt Disclosure [Abstract] Debt Disclosure [Abstract] Weighted Average Weighted Average [Member] Minimum purchase price as a percentage of fair market value Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent Loss before income tax benefit Pre-tax loss Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Type of Adoption [Domain] Accounting Standards Update [Domain] Long-Lived Tangible Asset [Axis] Long-Lived Tangible Asset [Axis] Schedule of Finite-Lived Intangible Assets Schedule of Intangible Assets and Goodwill [Table Text Block] Increase (decrease) in goodwill acquired, corresponding to accounts receivable remeasurement Goodwill, Period Increase (Decrease), Resulting From Remeasurement Of Receivables Goodwill, Period Increase (Decrease), Resulting From Remeasurement Of Receivables Deferred purchase consideration for a business combination Noncash or Part Noncash Acquisition, Deferred Purchase Consideration Noncash or Part Noncash Acquisition, Deferred Purchase Consideration Deferred revenue, net of current portion Contract with Customer, Liability, Noncurrent Auditor Location Auditor Location Weighted Average Amortization Period (Years) Estimated useful life Finite-Lived Intangible Asset, Useful Life Customer [Axis] Customer [Axis] Accrued liabilities and deferred revenue Increase (Decrease) in Accrued Liabilities and Deferred Revenue The increase (decrease) during the reporting period in the amount of expenses incurred but not yet paid and deferred rent. 401(k) Plan Retirement Benefits [Text Block] Use of Estimates Use of Estimates, Policy [Policy Text Block] Granted (in shares) Granted (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Document Annual Report Document Annual Report Other comprehensive loss Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Schedule of Share-based Compensation Expense Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Title of 12(b) Security Title of 12(b) Security Total assets Assets Deferred tax liabilities: Components of Deferred Tax Liabilities [Abstract] Plan Name [Domain] Plan Name [Domain] HalioDx developed technology HalioDX Developed Technology [Member] HalioDX Developed Technology Common stock, shares authorized (in shares) Common Stock, Shares Authorized Operating lease liability, net of current portion Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Operating Lease Liability Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Operating Lease Liability Indefinite-lived Intangible Assets Acquired as Part of Business Combination [Table] Indefinite-lived Intangible Assets Acquired as Part of Business Combination [Table] Cash paid for interest on debt Interest Paid, Excluding Capitalized Interest, Operating Activities Geographical [Domain] Geographical [Domain] Title of Individual [Axis] Title of Individual [Axis] Document Type Document Type Shares Available for Grant Share-based Compensation Arrangement by Share-based Payment Award, Additional General Disclosures [Abstract] Research and development Research and Development Expense Product and Service [Domain] Product and Service [Domain] Balance Sheet Components Supplemental Balance Sheet Disclosures [Text Block] Interest rate, stated percentage Debt Instrument, Interest Rate, Stated Percentage Acquisition-related contingent consideration, net of current portion Acquisition related contingent consideration Business Combination, Contingent Consideration, Liability Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Revolving credit facility Revolving Credit Facility [Member] Shares of common stock subject to outstanding options Employee And Non Employee Stock Option [Member] An arrangement whereby an employee or non-employee is entitled to receive in the future, subject to vesting and other restrictions, number of shares in the entity at a specified price, as defined in the agreement. Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Customers Representing >10% Of Total Revenue Major Customers [Member] Major Customers Net cash used in operating activities Net Cash Provided by (Used in) Operating Activities Tax credit carryforward Tax Credit Carryforward, Amount Expiration period after termination of service Share Based Compensation Arrangement by Share Based Payment Award, Expiration Period After Termination Expiration period of award after termination of service, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Schedule of Net Debt Obligation Schedule of Debt [Table Text Block] Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Furniture and fixtures Furniture and Fixtures [Member] Schedule of Long-term Debt Instruments [Table] Schedule of Long-term Debt Instruments [Table] Schedule of Operating Lease Expense and Measurement Of Lease Liabilities Lease, Cost [Table Text Block] Purchase period Share-based Compensation Arrangement by Share-based Payment Award, Purchase Period The purchase period under the plan, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Tax Credit Carryforward [Axis] Tax Credit Carryforward [Axis] Lease Contractual Term [Domain] Lease Contractual Term [Domain] Geographical [Axis] Geographical [Axis] Shares use to compute net loss per common share, basic (in shares) Weighted Average Number of Shares Outstanding, Basic Net loss per common share, diluted (in USD per share) Earnings Per Share, Diluted State State and Local Jurisdiction [Member] Amortization and write-off of debt discount and issuance costs Amortization of Debt Issuance Costs and Discounts Product revenue Product [Member] Permanent differences Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount Total identifiable assets acquired Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Finite-lived Intangible Assets Intangible Assets, Finite-Lived, Policy [Policy Text Block] Maximum fair market value of shares available to purchase per calendar year Share-based Compensation Arrangement by Share-based Payment Award, Maximum Value of Shares Per Employee The maximum fair market value of shares an employee can purchase under the plan per calendar year. International Non-US [Member] Foreign rate differential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount Headquarters and laboratory facilities, South San Francisco Headquarters And Laboratory Facilities South San Francisco [Member] Represents the lease for headquarters and laboratory space in South San Francisco, California that expires March 2026. Net comprehensive loss Comprehensive Income (Loss), Net of Tax, Attributable to Parent Intangible assets, net Intangible assets, net Intangible Assets, Net (Excluding Goodwill) Cost of revenue Cost of Revenue Period director must serve as board of director to receive grant to purchase shares Share Based Compensation Arrangement by Share based Payment Award, Period for Which Director Has to Serve as Board of Director to Receive Grant to Purchase Shares Represents the period for which director has to serve as board of director to receive grant to purchase shares. Deferred revenue Contract with Customer, Liability Equity Investments Investment, Policy [Policy Text Block] Net cash provided by financing activities Net Cash Provided by (Used in) Financing Activities Other comprehensive loss: Other Comprehensive Income (Loss), Net of Tax [Abstract] Maximum offering period Share-based Compensation Arrangement by Share-based Payment Award, Offering Period, Maximum The maximum offering period under the plan, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Deferred tax liability Deferred Income Tax Liabilities, Net Vesting period of awards granted Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period Proceeds from sale of equity securities Proceeds from Divestiture of Interest in Subsidiaries and Affiliates Voting power of person owning stock Share Based Compensation Arrangement by Share Based Payment Award Percentage of Voting Power of All Classes of Stock Voting power of all classes of stock, as a percent, of person owning stock as threshold for option terms under the entity's stock option plan. Interest expense or penalties related to unrecognized tax benefits Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense Outside director who was not previously an employee Outside Director Who Was Not Previously Employee [Member] Represents information pertaining to outside director, who was not previously an employee. Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Property and equipment, net Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment Schedule of Reconciliation of Tax Expense Computed at the Statutory Federal Rate Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Fair Value Measurements Fair Value Disclosures [Text Block] Accounts payable Accounts Payable, Current Concentration Risk Type [Axis] Concentration Risk Type [Axis] Debt Payment Tranche [Domain] Debt Payment Tranche [Domain] [Domain] for Debt Payment Tranche [Axis] Milestones Biopharmaceutical And Other - Milestones (Excluding Collaboration) [Member] Biopharmaceutical And Other - Milestones (Excluding Collaboration) Depreciation and amortization Depreciation, Depletion and Amortization Debt prepayment tranche three Debt Prepayment Tranche Three [Member] Debt Prepayment Tranche Three [Member] 2024 Finite-Lived Intangible Asset, Expected Amortization, Year Three Foreign Foreign Tax Authority [Member] Acquisitions Business Combinations Policy [Policy Text Block] Accumulated Other Comprehensive Loss AOCI Attributable to Parent [Member] Supplies Increase (Decrease) in Inventories Dividends declared Dividends Payable Common stock, shares outstanding (in shares) Common Stock, Shares, Outstanding Financial Instruments [Domain] Financial Instruments [Domain] Accounts payable Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable Revenue: Revenues [Abstract] Goodwill Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block] ASU 2014-09 Accounting Standards Update 2014-09 [Member] Document Period End Date Document Period End Date Unusual or Infrequent Item, or Both [Domain] Unusual or Infrequent Item, or Both [Domain] Lease Contractual Term [Axis] Lease Contractual Term [Axis] Entity Central Index Key Entity Central Index Key Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Line of Credit Facility, Lender [Domain] Line of Credit Facility, Lender [Domain] Other assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Assets Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Stock Options Outstanding and Unvested Stock Units Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Acquired Indefinite-lived Intangible Assets [Line Items] Acquired Indefinite-lived Intangible Assets [Line Items] Intangible asset acquired Number of Intangible Assets Acquired Number of Intangible Assets Acquired Sale of common stock in a public offering, net of offering costs Stock Issued And Sold During Period Value In Private Placement Value of shares issued and sold during the period in a private placement. State Deferred State and Local Income Tax Expense (Benefit) Investing activities Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract] Schedule of Property and Equipment Property, Plant and Equipment [Table Text Block] Research and development credits Deferred Tax Assets, Tax Credit Carryforwards, Research Decipher Biosciences Decipher Biosciences [Member] Decipher Biosciences Income Statement Location [Domain] Income Statement Location [Domain] Gross decreases—tax position in prior period Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions Business Acquisition, Pro Forma Information, Nonrecurring Adjustment [Line Items] Business Acquisition, Pro Forma Information, Nonrecurring Adjustment [Line Items] Additional shares authorized (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized Prosigna product technology Prosigna product technology Prosigna Developed Product Technology [Member] Developed Product Technology [Member] Total property and equipment, net Property, Plant and Equipment, Net Long-term debt Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-term Debt Other liabilities Other Liabilities, Noncurrent Pension liability Defined Benefit Plan, Benefit Obligation Interest and dividend income Other Nonoperating Income (Expense), Interest And Dividend Income Other Nonoperating Income (Expense), Interest And Dividend Income Lender Name [Axis] Lender Name [Axis] Schedule of Future Aggregate Amortization Expense Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table] Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table] Debt Instrument [Line Items] Debt Instrument [Line Items] Additional cash to be paid Business Combination, Contingent Consideration, Cash To Be Paid Business Combination, Contingent Consideration, Cash To Be Paid Payment of long-term debt Repayments of long-term debt Repayments of Long-term Debt Trading Symbol Trading Symbol Earnings Per Share [Abstract] Earnings Per Share [Abstract] Stock-based compensation expense (ESPP) Adjustments To Additional Paid In Capital Share Based Compensation ESPP Amount of increase in additional paid-in capital (APIC) resulting from ESPP stock-based compensation expense. Total revenues Business Acquisition, Pro Forma Revenue Total property and equipment, at cost Property, Plant and Equipment, Gross Decipher trade names Decipher Biosciences Trade Names [Member] Decipher Biosciences Trade Names Options vested and expected to vest at the end of the period (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Bank Time Deposits Bank Time Deposits [Member] Line of Credit Facility [Table] Line of Credit Facility [Table] Balance at beginning of the period (in USD per share) Balance at the end of the period (in USD per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Shares granted as initial grant (in shares) Share Based Compensation Arrangement by Share Based Payment Award, Options, Initial Grants Gross number of share options (or share units) granted to each individual as an initial grant. Long-term debt Long-term Debt, Excluding Current Maturities Schedule of Goodwill [Table] Schedule of Goodwill [Table] Share-based compensation expense Share-based Payment Arrangement, Expense Incurred liabilities in acquisition Liabilities incurred Business Combination, Consideration Transferred, Liabilities Incurred Unusual or Infrequent Item, or Both [Axis] Unusual or Infrequent Item, or Both [Axis] Options vested and exercisable at the end of the period Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Research Tax Credit Carryforward Research Tax Credit Carryforward [Member] Entity Current Reporting Status Entity Current Reporting Status Weighted-average minimum volatility Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum Defined Contribution Plan Disclosure [Line Items] Defined Contribution Plan Disclosure [Line Items] Option price as a percentage of estimated fair value of shares to person owning more than 10% of voting power stock Share based Compensation Arrangement by Share based Payment Award, Purchase Price of Stock, Percentage for Grants to Persons Who Owned Specified Percentage of Class of Stock Option price as a percentage of estimated fair value of shares on date of grant to a person owning stock representing specified percentage of voting power of all classes of stock. Current portion of operating lease liability Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Current Operating Lease Liability Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Current Operating Lease Liability Schedule of Income before Income Tax, Domestic and Foreign Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block] Construction-in-process Construction in Progress [Member] Gain on disposal of property and equipment Gain (Loss) on Disposition of Property Plant Equipment Issuance of common stock on exercise of stock options and vesting of restricted stock units (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options and Non-Option Equity Instruments, Exercises in Period Share-based Compensation Arrangement by Share-based Payment Award, Options and Non-Option Equity Instruments, Exercises in Period Cash, cash equivalents and restricted cash at beginning of year Cash, cash equivalents and restricted cash at end of year Total cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Tax Credit Carryforward, Name [Domain] Tax Credit Carryforward, Name [Domain] United States UNITED STATES Number of shares issued in transaction (in shares) Sale of Stock, Number of Shares Issued in Transaction Common stock, par value (in USD per share) Par value of shares of common stock (in USD per share) Common Stock, Par or Stated Value Per Share Discount rate Measurement Input, Discount Rate [Member] Development services Biopharmaceutical And Other - Development Services [Member] Biopharmaceutical And Other - Development Services Risk-free maximum interest rate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum Schedule of Third-party Payers as a Percentage of Total Schedules of Concentration of Risk, by Risk Factor [Table Text Block] Statement of Comprehensive Income [Abstract] Current assets: Assets, Current [Abstract] Gross Carrying Amount Finite-Lived Intangible Assets, Gross Total number of shares reserved for issuance (in shares) Common Stock, Capital Shares Reserved for Future Issuance Income Taxes Income Tax, Policy [Policy Text Block] LIBOR London Interbank Offered Rate (LIBOR) [Member] In-process research and development Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs Cash and cash equivalents Cash and Cash Equivalents, Fair Value Disclosure Entity Address, Postal Zip Code Entity Address, Postal Zip Code Equity Interest Type [Axis] Equity Interest Type [Axis] Testing revenue Testing [Member] Testing [Member] Exercised (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Revenue Recognition and Cost of Revenue Revenue from Contract with Customer [Policy Text Block] Shares use to compute net loss per common share, diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted United States Income (Loss) from Continuing Operations before Income Taxes, Domestic Income Taxes Income Tax Disclosure [Text Block] Number of additional shares reserved for issuance (in shares) Common Stock Capital Additional Shares Reserved for Future Issuance Aggregate number of additional common shares reserved for future issuance under the plan. Over-Allotment Option Over-Allotment Option [Member] Termination fee on loan, percentage of revolving line of credit Debt Instrument, Early Termination Fee, Percentage Debt Face Amount Debt Instrument, Early Termination Fee, Percentage Debt Face Amount Non deductible officers' compensation Effective Income Tax Rate Reconciliation, Nondeductible Expense, Officer Compensation, Amount Effective Income Tax Rate Reconciliation, Nondeductible Expense, Officer Compensation, Amount Long-term Debt, Type [Axis] Long-term Debt, Type [Axis] Related Party [Domain] Related Party [Domain] Schedule of Activity Under the Company's Stock Incentive Plans Share-based Payment Arrangement, Option, Activity [Table Text Block] Basis spread on variable rate Debt Instrument, Basis Spread on Variable Rate Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] Stockholders' Equity Stockholders' Equity Note Disclosure [Text Block] Lapse of statute of limitations Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations 2026 Finite-Lived Intangible Asset, Expected Amortization, Year Five Schedule of Outstanding Common Stock Equivalents Excluded from Diluted Net Loss per Common Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Facilities in Marseille, France Facilities in Marseille, France [Member] Facilities in Marseille, France Fair Value of Financial Instruments Fair Value of Financial Instruments, Policy [Policy Text Block] Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Auditor Firm ID Auditor Firm ID Class of Stock [Line Items] Class of Stock [Line Items] Stock-based Compensation, employees Employee Stock Option Excluding Bonus Compensation [Member] An arrangement whereby an employee is entitled to receive in the future, subject to vesting and other restrictions, a number of shares in the entity at a specified price, as defined in the agreement, excluding options granted as bonus compensation. Credit Facility [Axis] Credit Facility [Axis] Purchase obligation Purchase Obligation Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Entity Address, Address Line One Entity Address, Address Line One Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Entity Address, Address Line Two Entity Address, Address Line Two Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Accumulated depreciation and amortization Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Issuance of common stock under employee stock purchase plan (ESPP) Stock Issued During Period, Value, Employee Stock Purchase Plan Weighted average grant date fair value (in USD per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Canadian Canada Revenue Agency [Member] General and administrative General and Administrative Expense [Member] Entity Shell Company Entity Shell Company Weighted-average expected term Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term Total current liabilities Liabilities, Current Employee stock purchase plan Employee Stock [Member] Payment of taxes on vested restricted stock units Payment, Tax Withholding, Share-based Payment Arrangement Cash considerations paid in acquisition Cash transferred Payments to Acquire Businesses, Gross Prepayment premium Debt Instrument, Prepayment Premium Amount of prepayment premium waived. Defined Contribution Plan [Table] Defined Contribution Plan [Table] Line of credit facility, maximum borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity Issuance of common stock on exercise of stock options and vesting of restricted stock units Share-based Compensation Arrangement by Share-based Payment Award, Value, Options and Non-Option Equity Instruments, Exercises in Period Share-based Compensation Arrangement by Share-based Payment Award, Value, Options and Non-Option Equity Instruments, Exercises in Period French Ministry of the Economy, Finance and Industry, France [Member] Money Market Funds Money Market Funds [Member] Effect of foreign currency translation on Goodwill acquired - HalioDx Goodwill, Foreign Currency Translation Gain (Loss) Cash and cash equivalents Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents Schedule of Estimated Useful Life for Identifiable Acquisition-Related Intangibles Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block] Options vested and expected to vest at the end of the period Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Maximum annual increase as a percentage in outstanding shares on the last day of the preceding fiscal year Share-based Compensation Arrangement by Share-based Payment Award, Percentage of Outstanding Stock Maximum Current Fiscal Year End Date Current Fiscal Year End Date Line of Credit Facility [Line Items] Line of Credit Facility [Line Items] Operating Leased Assets [Line Items] Operating Leased Assets [Line Items] Statement [Table] Statement [Table] ROU assets Deferred Tax Liabilities, Right-of-Use Assets Deferred Tax Liabilities, Right-of-Use Assets Recent Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Current portion of financing lease liability Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Current Financing Lease Liability Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Current Financing Lease Liability Other assets Increase (Decrease) in Other Noncurrent Assets Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract] Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract] Debt Prepayment Tranche [Axis] Debt Prepayment Tranche [Axis] Debt Prepayment Tranche [Axis] Statistical Measurement [Axis] Statistical Measurement [Axis] Finance Lease, Liability, Statement of Financial Position [Extensible Enumeration] Finance Lease, Liability, Statement of Financial Position [Extensible Enumeration] U.S. federal taxes at statutory rate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount Vested (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares Net Carrying Amount Finite-Lived Intangible Assets, Net Goodwill Goodwill Goodwill at beginning of period Goodwill at end of period Goodwill Schedule of Fair Value Measurement Unobservable Inputs Fair Value Measurement Inputs and Valuation Techniques [Table Text Block] Cost of testing revenue Cost of Sales [Member] Contract testing Biopharmaceutical And Other - Contract Testing [Member] Biopharmaceutical And Other - Contract Testing Early termination fee on loan Debt Instrument, Early Termination Fee Debt Instrument, Early Termination Fee Tax credits Effective Income Tax Rate Reconciliation, Tax Credit, Amount Foreign Current Foreign Tax Expense (Benefit) Schedule of Goodwill Schedule of Goodwill [Table Text Block] Scenario [Domain] Scenario [Domain] Adjustments to reconcile net loss to net cash used in operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Pension Plan Pension Plan [Member] Phantom Share Units (PSUs) Phantom Share Units (PSUs) [Member] Computer equipment Computer Equipment [Member] United Healthcare United Healthcare [Member] Represents information pertaining to United Healthcare, a significant third-party payer. Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Schedule of Finite-Lived Intangible Assets [Table] Schedule of Finite-Lived Intangible Assets [Table] Total deferred Deferred Income Tax Expense (Benefit) Options vested and expected to vest at the end of the period Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term